Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311909 · ClinicalTrials.gov registry record · Phase 2
Thalamic Deep Brain Stimulation for Tourette Syndrome
A Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00311909: Completed Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
NCT00311909 is a Phase 2 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00311909, a Phase 2 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether deep brain stimulation is effective at reducing tic frequency and severity in adults with Tourette syndrome.
Interventions
- DEVICE Thalamic deep brain stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
What the finished NCT00311909 record still lists
NCT00311909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Thalamic deep brain stimulation is the first listed.
NCT00311909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00311909 about?
NCT00311909 is a clinical study titled "Thalamic Deep Brain Stimulation for Tourette Syndrome". The purpose of this study is to determine whether deep brain stimulation is effective at reducing tic frequency and severity in adults with Tourette syndrome.
What is the current status of trial NCT00311909?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2005-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00311909?
The interventions under investigation include: Thalamic deep brain stimulation (DEVICE).
Who is sponsoring clinical trial NCT00311909?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00311909's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia